Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, "Sapienza" University of Rome, Rome, Italy.
Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, and Fondazione Luigi Villa, Università degli Studi di Milano, Milan, Italy.
Endocrine. 2021 Feb;71(2):484-493. doi: 10.1007/s12020-020-02553-5. Epub 2021 Jan 12.
To evaluate clinical features, treatments, and outcomes of osteoporotic patients admitted to internal medicine and geriatric wards compared with non-osteoporotic patients (REPOSI registry).
We studied 4714 patients hospitalized between 2010 and 2016. We reported age, sex, educational level, living status, comorbidities and drugs taken, Cumulative Illness Rating Scale (CIRS), Barthel Index, Short-Blessed Test, 4-item Geriatric Depression Scale, serum hemoglobin, creatinine, and clinical outcomes. Osteoporosis was defined based on the diagnoses recorded at admission, according to the following ICD9: 733, 805-813, 820-823.
Twelve percent of the patients had a preadmission diagnosis of osteoporosis. Only 20% of these had been prescribed oral bisphosphonates; 34% were taking vitamin D supplements. Osteoporotic patients were significantly older, with lower BMI, higher CIRS, and taking more drugs. They were significantly more depressed, less independent, with a higher severity of cognitive impairment compared with non-osteoporotic patients. At discharge, the number of patients receiving treatment for osteoporosis did not change. Length of stay and inhospital mortality did not differ between groups. Osteoporotic patients were more frequently nonhome discharged compared with those without osteoporosis (14.8 vs. 7.9%, p = 0.0007), mostly discharged to physical therapy or rehabilitation (8.8 vs. 2.5% of patients, p < 0.0001). Among osteoporotic patients deceased 3 months after discharge, the number of those treated with vitamin D, with or without calcium supplements, was significantly lower compared with survivors (12 vs. 32%, p = 0.0168).
The diagnosis of osteoporosis is poorly considered both during hospital stay and at discharge; osteoporotic patients are frailer compared to non-osteoporotic patients.
评估 2010 年至 2016 年间入住内科和老年病房的骨质疏松症患者与非骨质疏松症患者的临床特征、治疗方法和结局(REPOSI 登记研究)。
我们研究了 4714 名住院患者。报告了年龄、性别、教育水平、居住状况、合并症和用药情况、累积疾病评分量表(CIRS)、巴氏指数、简短Blessed 测试、4 项老年抑郁量表、血清血红蛋白、肌酐和临床结局。骨质疏松症根据入院诊断,按照以下 ICD9 进行诊断:733、805-813、820-823。
12%的患者入院前诊断为骨质疏松症。仅有 20%的患者开具了口服双磷酸盐;34%的患者在服用维生素 D 补充剂。与非骨质疏松症患者相比,骨质疏松症患者年龄较大,BMI 较低,CIRS 较高,用药较多。他们的抑郁程度明显更高,独立性较低,认知障碍程度也较高。出院时,接受骨质疏松症治疗的患者数量没有变化。两组的住院时间和院内死亡率没有差异。与非骨质疏松症患者相比,骨质疏松症患者更常非居家出院(14.8%比 7.9%,p=0.0007),大多出院至物理治疗或康复科(8.8%比 2.5%的患者,p<0.0001)。在出院后 3 个月死亡的骨质疏松症患者中,接受维生素 D 治疗(无论是否补充钙)的患者明显少于幸存者(12%比 32%,p=0.0168)。
在住院期间和出院时,骨质疏松症的诊断都考虑不足;与非骨质疏松症患者相比,骨质疏松症患者的身体更脆弱。